Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of L9LS in Malian Women of Childbearing Potential
NCT07060508Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2025
- Primary completion
- Apr 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of L9LS in malaria, sponsored by National Institute of Allergy and Infectious Diseases. Started Jul 2025; status: completed.
02
Drugs
L9LS
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07060508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07060508.